ENTRESTO Market, By Indication (Chronic Heart Failure (CHF), Symptomatic heart failure with left ventricular systolic dysfunction in pediatric patients), By Dosage Forms (Film-coated tablets, and Film-coated oral pellets within capsules), By Strength (24/26 mg, 49/51 mg , 97/103 mg, 6 mg/6 mg, and 15 mg/16 mg), By Age Group (Adults and Pediatric), By Gender (Male and Female), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By End User (Hospitals and Clinics, Cardiology Centers, Long-Term Care Facilities, Ambulatory Care Centers, Homecare Settings, and Others (Academic and Research Institutes, etc.)), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
Select a License Type that Suits your Business Needs
US$ 2,000
Two thousand dollars
Single User License
( Full Report )
US$ 4,500
US$ 3,000
Three thousand dollars
Frequently purchased
Multi User License
( Full Report )
US$ 7,000
US$ 5,000
Five thousand dollars
Corporate User License
( Full Report )
US$ 10,000
US$ 6000
Six thousand dollars
Client Testimonials
Client Testimonials
Our Clients
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.

860519526
9001:2015
27001:2022